FDAnews Drug Daily Bulletin

ALLERGAN 3Q PROFIT BEATS ESTIMATES

Nov. 2, 2005
A A

Allergan Inc., maker of eye care products and the Botox wrinkle injection, said Tuesday that its third-quarter profit jumped 64 percent. The results beat Wall Street estimates. The company also raised its guidance for 2005, sending its shares up $2.14, or 2.4 percent, to $91.44 in morning trading on the New York Stock Exchange. The stock has traded between $69.01 and $95.43 over the past year.
Yahoo News